|
시장보고서
상품코드
2055268
영상 진단 CRO 시장 : 서비스 유형별, 영상 진단 모달리티별, 치료 영역별, 임상시험 단계별, 최종사용자별, 지역별Imaging CRO Market, By Service Type, By Imaging Modality, By Therapeutic Area, By Clinical Trial Phase, By End User, By Geography |
||||||
영상 진단 CRO(Contract Research Organizations) 시장은 2026년 61억 달러로 추정되고, 2033년에 106억 2,000만 달러에 이를 것으로 예상되고 있습니다. 또한, 2026-2033년 CAGR 8.3%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 61억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 8.30% | 2033년 시장 규모 예측 : | 106억 2,000만 달러 |
세계 영상진단 CRO 시장은 의료 산업에서 매우 중요한 분야로 부상하고 있으며, 의료 영상 기술의 개발과 발전에 있어 지대한 역할을 하고 있습니다. 영상진단 CRO는 임상시험 및 연구를 지원하기 위해 영상진단 프로토콜 설계, 영상 촬영, 분석, 판독 등 폭넓은 서비스를 제공하는 것을 전문으로 합니다. 이들 기관은 최첨단 기술과 전문 지식을 활용하여 고품질의 영상 진단 데이터를 제공함으로써, 제약사 및 생명공학 기업이 의약품 개발 과정에서 정보에 기반한 의사결정을 내릴 수 있도록 지원하고 있습니다. 만성 질환 유병률 증가에 더해, 맞춤형 의료에 대한 수요 증가와 효율적이며 비용 대비 효과가 높은 의약품 개발의 필요성이 맞물려 전 세계 영상진단 CRO 시장의 성장을 견인하고 있습니다. 의료 환경이 지속적으로 발전함에 따라, 혁신적인 치료법 개발을 가속화하고 환자의 치료 성과를 향상시키는 데 있어 영상진단 CRO의 역할은 점점 더 중요해지고 있습니다.
시장 역학
세계 영상진단 CRO 시장의 성장은 만성 질환 유병률 증가, 첨단 영상진단 기술에 대한 수요 증가, 효율적이고 비용 효율적인 의약품 개발 프로세스에 대한 필요성 증대 등 몇 가지 주요 요인에 의해 주도되고 있습니다. 고령화와 생활 방식의 변화로 인해 암, 심혈관 질환, 신경계 질환 등 만성 질환의 발병률이 증가하고 있으며, 이러한 질환의 진단 및 모니터링을 위해서는 첨단 영상 진단 기술이 필요합니다. 또한, 맞춤형 의료의 등장으로 표적 치료제 개발이 필요해졌으며, 이에 따라 환자 선정 및 치료 효과 평가 과정에서 영상 바이오마커에 대한 의존도가 높아지고 있습니다. 그러나 영상 진단 장비의 높은 비용, 복잡한 규제 요건, 이 분야의 숙련된 전문가 부족 등의 요인으로 인해 시장 성장이 저해될 가능성이 있습니다.
또한, 영상 프로토콜 및 데이터 관리 분야의 표준화 부재는 서로 다른 기관이나 연구 간에 영상 데이터의 신뢰성과 재현성을 확보하는 데 있어 영상 CRO에게 과제로 대두되고 있습니다. 이러한 과제들이 있음에도 불구하고, 인공지능, 머신러닝, 클라우드 컴퓨팅과 같은 기술의 발전이 영상 진단 분야를 혁신하고 있으며, 이에 따라 시장에는 큰 성장 기회가 열리고 있습니다. 이러한 기술을 통해 보다 신속하고 정확한 영상 분석이 가능해지며, 데이터 관리가 효율화되고 이해관계자간의 원격 협력이 촉진됩니다. 또한, PET/CT나 PET/MRI와 같은 하이브리드 영상 진단법의 도입이 확대됨에 따라, 다중 모달 영상 진단을 지원하는 영상 진단 CRO의 업무 범위가 확대될 것으로 예측됩니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 주요 지표(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)를 바탕으로 전 세계 영상진단 CRO 시장의 주요 시장 진출기업을 분석했습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 장비 모델 업그레이드, 시장 확대, 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 전 세계 영상진단 CRO 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 영상진단 CRO 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 영상 진단 CRO 시장 : 서비스 유형별, 2021-2033년
제5장 세계의 영상 진단 CRO 시장 : 영상 진단 모달리티별, 2021-2033년
제6장 세계의 영상 진단 CRO 시장 : 치료 영역별, 2021-2033년
제7장 세계의 영상 진단 CRO 시장 : 임상시험 단계별, 2021-2033년
제8장 세계의 영상 진단 CRO 시장 : 최종사용자별, 2021-2033년
제9장 세계의 영상 진단 CRO 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌과 조사 방법
LSHImaging CRO Market is estimated to be valued at USD 6.10 Bn in 2026 and is expected to reach USD 10.62 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 6.10 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.30% | 2033 Value Projection: | USD 10.62 Bn |
The global imaging CRO market has emerged as a crucial sector within the healthcare industry, playing a pivotal role in the development and advancement of medical imaging technologies. Imaging Contract Research Organizations (CROs) specialize in providing a wide range of services, including imaging protocol design, image acquisition, analysis, and interpretation, to support clinical trials and research studies. These organizations leverage cutting-edge technologies and expertise to deliver high-quality imaging data, enabling pharmaceutical and biotechnology companies to make informed decisions during the drug development process. The increasing prevalence of chronic diseases, coupled with the growing demand for personalized medicine and the need for efficient and cost-effective drug development, has fueled the growth of the global imaging CRO market. As the healthcare landscape continues to evolve, the role of imaging CROs is becoming increasingly important in accelerating the development of innovative therapies and improving patient outcomes.
Market Dynamics
The global imaging CRO market growth is driven by several key factors, including the increasing prevalence of chronic diseases, rising demand for advanced imaging technologies, and the growing need for efficient and cost-effective drug development processes. The aging population and changing lifestyles have led to a higher incidence of chronic conditions such as cancer, cardiovascular diseases, and neurological disorders, which require advanced imaging techniques for diagnosis and monitoring. Additionally, the advent of personalized medicine has necessitated the development of targeted therapies, which rely heavily on imaging biomarkers for patient selection and treatment response assessment. However, the market growth may be restrained by factors such as the high cost of imaging equipment, complex regulatory requirements, and the shortage of skilled professionals in the field.
Furthermore, the lack of standardization in imaging protocols and data management poses challenges for imaging CROs in ensuring the reliability and reproducibility of imaging data across different sites and studies. Despite these challenges, the market presents significant opportunities for growth, driven by technological advancements such as artificial intelligence, machine learning, and cloud computing, which are transforming the imaging landscape. These technologies enable faster and more accurate image analysis, streamline data management, and facilitate remote collaboration among stakeholders. Moreover, the increasing adoption of hybrid imaging modalities, such as PET/CT and PET/MRI, is expected to expand the scope of Imaging CROs in supporting multimodal imaging studies.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global Imaging CRO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Fujifilm Holdings Corporation, Agfa-Gevaert Group, Hitachi Medical Corporation, Carestream Health, Hologic, Inc., Toshiba Medical Systems, Mindray Medical International Limited, Varian Medical Systems, Esaote S.p.A., Bracco Imaging S.p.A., and Leica Biosystems
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global imaging CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global imaging CRO market
Market Segmentation
- Service Type Insights (Revenue, USD Bn, 2021 - 2033)
- Clinical Trial Imaging
- Preclinical Imaging
- Medical Imaging Data Management
- Image Processing & Analysis Services
- Regulatory Consultancy
- Others (Quality Control, etc.)
- Imaging Modality Insights (Revenue, USD Bn, 2021 - 2033)
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
- Ultrasound
- X-ray
- Optical Imaging
- Therapeutic Area Insights (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Neurology
- Cardiology
- Musculoskeletal Disorders
- Gastroenterology
- Endocrinology
- Others
- Clinical Trial Phase Insights (Revenue, USD Bn, 2021 - 2033)
- Phase I
- Phase II
- Phase III
- Phase IV
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Manufacturers
- Diagnostic Centers
- Contract Research Organizations
- Academic and Research Institutes
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Siemens Healthineers
- GE Healthcare
- Philips Healthcare
- Canon Medical Systems
- Fujifilm Holdings Corporation
- Agfa-Gevaert Group
- Hitachi Medical Corporation
- Carestream Health
- Hologic, Inc.
- Toshiba Medical Systems
- Mindray Medical International Limited
- Varian Medical Systems
- Esaote S.p.A.
- Bracco Imaging S.p.A.
- Leica Biosystems
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Imaging CRO Market, By Service Type
- Global Imaging CRO Market, By Imaging Modality
- Global Imaging CRO Market, By Therapeutic Area
- Global Imaging CRO Market, By Clinical Trial Phase
- Global Imaging CRO Market, By End User
- Global Imaging CRO Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Imaging CRO Market, By Service Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Clinical Trial Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Preclinical Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Medical Imaging Data Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Image Processing & Analysis Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Regulatory Consultancy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Quality Control, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Imaging CRO Market, By Imaging Modality, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Magnetic Resonance Imaging (MRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Computed Tomography (CT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Positron Emission Tomography (PET)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ultrasound
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- X-ray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Optical Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Imaging CRO Market, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Musculoskeletal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Imaging CRO Market, By Clinical Trial Phase, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Phase I
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Phase II
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Phase III
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Phase IV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Imaging CRO Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Medical Device Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Imaging CRO Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Imaging Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Phase, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Imaging Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Phase, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Imaging Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Phase, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Imaging Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Phase, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Imaging Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Phase, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Imaging Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Phase, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Canon Medical Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fujifilm Holdings Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agfa-Gevaert Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hitachi Medical Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Carestream Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Toshiba Medical Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mindray Medical International Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Varian Medical Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Esaote S.p.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bracco Imaging S.p.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Leica Biosystems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
